ArticleClinical and experimental medicine2024

Assessment of bone turnover markers and DXA parameters to predict bone metastasis progression during zoledronate treatment: a single-center experience.

Stella D'Oronzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.